June 9, 2021

Know Labs Announces Successful Results from Pre-Clinical Study Validating Bio-RFID™ Platform Technology

SEATTLE–(BUSINESS WIRE)—- $KNWN–Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced successful results from an independent pre-clinical study validating the company’s Bio-RFID™ platform technology. Know Labs is developing a novel medical device using the Bio-RFID technology that it expects will be the world’s first non-invasive continuous glucose monitor, making finger sticks and micro-needle monitoring devices obsolete and changing care for the worl


Leave Comment


Your Name *
Your Email *
Your Website
Comment *